These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 11583714
1. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats. Kobayashi N, Mori Y, Nakano S, Tsubokou Y, Kobayashi T, Shirataki H, Matsuoka H. Atherosclerosis; 2001 Oct; 158(2):359-68. PubMed ID: 11583714 [Abstract] [Full Text] [Related]
2. Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats. Higashi T, Kobayashi N, Hara K, Shirataki H, Matsuoka H. J Cardiovasc Pharmacol; 2000 Apr; 35(4):564-71. PubMed ID: 10774787 [Abstract] [Full Text] [Related]
3. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats. Hara K, Kobayashi N, Nakano S, Mori Y, Tsubokou Y, Matsuoka H. Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031 [Abstract] [Full Text] [Related]
4. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. Hara K, Kobayashi N, Watanabe S, Tsubokou Y, Matsuoka H. Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177 [Abstract] [Full Text] [Related]
5. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats. Kobayashi N, Nishikimi T, Horinaka S, Ishimitsu T, Matsuoka H. Atherosclerosis; 2001 Jun; 156(2):255-65. PubMed ID: 11395021 [Abstract] [Full Text] [Related]
6. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T. Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146 [Abstract] [Full Text] [Related]
7. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. Brilla CG, Scheer C, Rupp H. J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122 [Abstract] [Full Text] [Related]
8. Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats. Kobayashi N, Mori Y, Nakano S, Tsubokou Y, Shirataki H, Matsuoka H. J Hypertens; 2001 Apr; 19(4):795-801. PubMed ID: 11330883 [Abstract] [Full Text] [Related]
9. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats. Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M. Blood Press Suppl; 1994 Apr; 5():94-8. PubMed ID: 7889211 [Abstract] [Full Text] [Related]
10. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. Kobayashi N, Nakano S, Mita S, Kobayashi T, Honda T, Tsubokou Y, Matsuoka H. J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044 [Abstract] [Full Text] [Related]
11. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishimura Y, Chatani F, Iwao H. J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806 [Abstract] [Full Text] [Related]
12. Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats. Kobayashi N, Higashi T, Hara K, Shirataki H, Matsuoka H. Cardiovasc Res; 1999 Dec; 44(3):518-26. PubMed ID: 10690283 [Abstract] [Full Text] [Related]
13. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Mizuno K, Niimura S, Katoh K, Fukuchi S. Life Sci; 1994 Dec; 54(25):1987-94. PubMed ID: 8201847 [Abstract] [Full Text] [Related]
14. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA. Kobayashi N, Hara K, Watanabe S, Higashi T, Matsuoka H. Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821 [Abstract] [Full Text] [Related]
15. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. Yamakawa H, Jezova M, Ando H, Saavedra JM. J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312 [Abstract] [Full Text] [Related]
17. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Kobayashi N, Kobayashi K, Hara K, Higashi T, Yanaka H, Yagi S, Matsuoka H. Am J Hypertens; 1999 May; 12(5):483-91. PubMed ID: 10342786 [Abstract] [Full Text] [Related]
18. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. Bennai F, Morsing P, Paliege A, Ketteler M, Mayer B, Tapp R, Bachmann S. J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150 [Abstract] [Full Text] [Related]
19. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. Hanatani A, Yoshiyama M, Kim S, Omura T, Toda I, Akioka K, Teragaki M, Takeuchi K, Iwao H, Takeda T. J Mol Cell Cardiol; 1995 Sep; 27(9):1905-14. PubMed ID: 8523451 [Abstract] [Full Text] [Related]
20. Effects of cilnidipine on nitric oxide and endothelin-1 expression and extracellular signal-regulated kinase in hypertensive rats. Kobayashi N, Mori Y, Mita S, Nakano S, Kobayashi T, Tsubokou Y, Matsuoka H. Eur J Pharmacol; 2001 Jun 22; 422(1-3):149-57. PubMed ID: 11430925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]